Role of prenatal ultrasonography in women with positive screen for Down syndrome on the basis of maternal serum markers
- 31 October 1995
- journal article
- clinical trial
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 173 (4) , 1030-1035
- https://doi.org/10.1016/0002-9378(95)91322-x
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Chromosomal defects and outcome in 1015 fetuses with increased nuchal translucencyUltrasound in Obstetrics & Gynecology, 1995
- Ultrasonographically detectable markers of fetal chromosomal defectsUltrasound in Obstetrics & Gynecology, 1993
- Elevated second trimester maternal serum β‐HCG concentrations and subsequent adverse pregnancy outcomeAmerican Journal of Medical Genetics, 1992
- Increased maternal serum alpha‐fetoprotein and human chorionic gonadotropin in compromised pregnancies other than for neural tube defects or Down syndromePrenatal Diagnosis, 1992
- Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy.BMJ, 1992
- Fetal Abdominal Hyperechoic Mass: Diagnosis and ManagementFetal Diagnosis and Therapy, 1992
- Humeral Shortening in Second-Trimester Fetuses With Down SyndromeObstetrics & Gynecology, 1991
- Maternal serum screening for Down's syndrome in early pregnancy.BMJ, 1988
- Low second trimester maternal serum unconjugated oestriol in pregnancies with Down's syndromeBJOG: An International Journal of Obstetrics and Gynaecology, 1988
- Sonographic Identification of Second-Trimester Fetuses with Down's SyndromeNew England Journal of Medicine, 1987